Beam Therapeutics (BEAM) Accumulated Depreciation & Amortization: 2019-2025
Historic Accumulated Depreciation & Amortization for Beam Therapeutics (BEAM) over the last 6 years, with Sep 2025 value amounting to $88.6 million.
- Beam Therapeutics' Accumulated Depreciation & Amortization rose 32.91% to $88.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $321.5 million, marking a year-over-year increase of 37.61%. This contributed to the annual value of $72.1 million for FY2024, which is 43.69% up from last year.
- Per Beam Therapeutics' latest filing, its Accumulated Depreciation & Amortization stood at $88.6 million for Q3 2025, which was up 6.53% from $83.2 million recorded in Q2 2025.
- In the past 5 years, Beam Therapeutics' Accumulated Depreciation & Amortization registered a high of $88.6 million during Q3 2025, and its lowest value of $10.3 million during Q1 2021.
- In the last 3 years, Beam Therapeutics' Accumulated Depreciation & Amortization had a median value of $61.2 million in 2024 and averaged $61.3 million.
- Data for Beam Therapeutics' Accumulated Depreciation & Amortization shows a peak YoY soared of 94.78% (in 2021) over the last 5 years.
- Quarterly analysis of 5 years shows Beam Therapeutics' Accumulated Depreciation & Amortization stood at $16.1 million in 2021, then surged by 87.61% to $30.2 million in 2022, then skyrocketed by 66.33% to $50.2 million in 2023, then soared by 43.69% to $72.1 million in 2024, then skyrocketed by 32.91% to $88.6 million in 2025.
- Its Accumulated Depreciation & Amortization was $88.6 million in Q3 2025, compared to $83.2 million in Q2 2025 and $77.6 million in Q1 2025.